A review of genetic risk in systemic lupus erythematosus

References

• Wang L, Wang F-S, Gershwin ME. Human autoimmune diseases: a comprehensive update. J Intern Med. 2015;278(4):369–395. doi: 10.1111/joim.12395
   PubMed Web of Science ®Google Scholar
• Barber MRW, Drenkard C, Falasinnu T, et al. Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol. 2021;17(9):515–532. doi: 10.1038/s41584-021-00668-1
   PubMed Web of Science ®Google Scholar
• Chen L, Morris DL, Vyse TJ. Genetic advances in systemic lupus erythematosus: an update. Curr Opin Rheumatol. 2017;29(5):423–433. doi: 10.1097/BOR.0000000000000411
   PubMed Web of Science ®Google Scholar
• Yin X, Kim K, Suetsugu H, et al. Meta-analysis of 208370 East Asians identifies 113 susceptibility loci for systemic lupus erythematosus. Ann Rheumatic Dis. 2020;80(5):632–640. doi: 10.1136/annrheumdis-2020-219209
   PubMed Web of Science ®Google Scholar
• Wen L, Zhu C, Zhu Z, et al. Exome-wide association study identifies four novel loci for systemic lupus erythematosus in Han Chinese population. Ann Rheumatic Dis. 2017;77(3):417. doi: 10.1136/annrheumdis-2017-211823
   PubMed Web of Science ®Google Scholar
• Tangtanatakul P, Thumarat C, Satproedprai N, et al. Meta-analysis of genome-wide association study identifies FBN2 as a novel locus associated with systemic lupus erythematosus in Thai population. Arthritis Res Ther. 2020;22(1). doi: 10.1186/s13075-020-02276-y
   PubMed Web of Science ®Google Scholar
• Akizuki S, Ishigaki K, Kochi Y, et al. PLD4 is a genetic determinant to systemic lupus erythematosus and involved in murine autoimmune phenotypes. Ann Rheumatic Dis. 2019;78(4):509–518. doi: 10.1136/annrheumdis-2018-214116
   PubMed Web of Science ®Google Scholar
• Julià A, López-Longo FJ, Venegas JJP, et al. Genome-wide association study meta-analysis identifies five new loci for systemic lupus erythematosus. Arthritis Res Ther. 2018;20(1). doi: 10.1186/s13075-018-1604-1
   PubMedGoogle Scholar
• Zhang H, Zhang Y, Wang Y-F, et al. Meta-analysis of GWAS on both Chinese and European populations identifies GPR173 as a novel X chromosome susceptibility gene for SLE. Arthritis Res Ther. 2018;20(1). doi: 10.1186/s13075-018-1590-3
   Google Scholar
• Wang YF, Wei W, Tangtanatakul P, et al. Identification of shared and asian-specific loci for systemic lupus erythematosus and evidence for roles of type iii interferon signaling and lysosomal function in the disease: a multi-ancestral genome-wide association study. Arthritis & rheumat. 2022;74(5):840–848. doi: 10.1002/art.42021
   PubMed Web of Science ®Google Scholar
• Wang Y-F, Zhang Y, Zhu Z, et al. Identification of ST3AGL4, MFHAS1, CSNK2A2 and CD226 as loci associated with systemic lupus erythematosus (SLE) and evaluation of SLE genetics in drug repositioning. Ann Rheumatic Dis. 2018;77(7):1078–1084. doi: 10.1136/annrheumdis-2018-213093
   PubMed Web of Science ®Google Scholar
• Wang Y-F, Zhang Y, Lin Z, et al. Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups. Nat Commun. 2021;12(1). doi: 10.1038/s41467-021-21049-y
   Web of Science ®Google Scholar
• Song Q, Lei Y, Shao L, et al. Genome-wide association study on Northern Chinese identifies KLF2, DOT1L and STAB2 associated with systemic lupus erythematosus. Rheumatology. 2021;60(9):4407–4417. doi: 10.1093/rheumatology/keab016
   PubMed Web of Science ®Google Scholar
• Morris DL, Sheng Y, Zhang Y, et al. Genome-wide association meta-analysis in Chinese and European individuals identifies ten new loci associated with systemic lupus erythematosus. Nature Genet. 2016;48(8):940–946. doi: 10.1038/ng.3603
   PubMed Web of Science ®Google Scholar
• López-Cortegano E, Caballero A. Inferring the nature of missing heritability in human traits using data from the GWAS catalog. Genetics. 2019;212(3):891–904. doi: 10.1534/genetics.119.302077
   PubMed Web of Science ®Google Scholar
• MacArthur J, Bowler E, Cerezo M, et al. The new NHGRI-EBI catalog of published genome-wide association studies (GWAS Catalog). Nucleic Acids Res. 2016;45(D1):D896–D901. doi: 10.1093/nar/gkw1133
   PubMed Web of Science ®Google Scholar
• Connolly JJ, Hakonarson H. Role of cytokines in systemic lupus erythematosus: recent progress from GWAS and sequencing. J Biomed And Biotech. 2012;2012:1–17. doi: 10.1155/2012/798924
   PubMedGoogle Scholar
• Rao S, Yao Y, Bauer DE. Editing GWAS: experimental approaches to dissect and exploit disease-associated genetic variation. Genome Med. 2021;13(1). doi: 10.1186/s13073-021-00857-3
   PubMed Web of Science ®Google Scholar
• Giambartolomei C, Liu JZ, Zhang W, et al. A Bayesian framework for multiple trait colocalization from summary association statistics. Bioinformatics. 2018;34(15):2538–2545. doi: 10.1093/bioinformatics/bty147
   PubMed Web of Science ®Google Scholar
• Maller JB, McVean G, Byrnes J, et al. Bayesian refinement of association signals for 14 loci in 3 common diseases. Nature Genet. 2012;44(12):1294–1301. doi: 10.1038/ng.2435
   PubMed Web of Science ®Google Scholar
• Chung CC, Ciampa J, Yeager M, et al. Fine mapping of a region of chromosome 11q13 reveals multiple independent loci associated with risk of prostate cancer. Hum Mol Genet. 2011;20(14):2869–2878. doi: 10.1093/hmg/ddr189
   PubMed Web of Science ®Google Scholar
• Allen HL, Estrada K, Lettre G, et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature. 2010;467(7317):832–838. doi: 10.1038/nature09410
   PubMed Web of Science ®Google Scholar
• Newcombe PJ, Conti DV, Richardson S. JAM: a scalable bayesian framework for joint analysis of marginal SNP effects. Genet Epidemiol. 2016;40(3):188–201. doi: 10.1002/gepi.21953
   PubMed Web of Science ®Google Scholar
• Benner C, Spencer CCA, Havulinna AS, et al. FINEMAP: efficient variable selection using summary data from genome-wide association studies. Bioinformatics. 2016;32(10):1493–1501. doi: 10.1093/bioinformatics/btw018
   PubMed Web of Science ®Google Scholar
• Wang G, Sarkar A, Carbonetto P, et al. A simple new approach to variable selection in regression, with application to genetic fine-mapping. J R Stat Soc Series B Stat Methodol. 2018;82(5): 1273–1300 .
   Web of Science ®Google Scholar
• Zou Y, Carbonetto P, Wang G, et al. Fine-mapping from summary data with the “Sum of single effects” model. PLoS Genet. 2022;18(7):e1010299. doi: 10.1371/journal.pgen.1010299
   PubMed Web of Science ®Google Scholar
• Kichaev G, Yang W-Y, Lindstrom S, et al. Integrating functional data to prioritize causal variants in statistical fine-mapping studies. PLoS Genet. 2014;10(10):e1004722. doi: 10.1371/journal.pgen.1004722
   PubMed Web of Science ®Google Scholar
• Morris AP. Transethnic meta-analysis of genomewide association studies. Genet Epidemiol. 2011;35(8):809–822. doi: 10.1002/gepi.20630
   PubMed Web of Science ®Google Scholar
• Mägi R, Horikoshi M, Sofer T, et al. Trans-ethnic meta-regression of genome-wide association studies accounting for ancestry increases power for discovery and improves fine-mapping resolution. Hum Mol Genet. 2017;26(18):3639–3650. doi: 10.1093/hmg/ddx280
   PubMed Web of Science ®Google Scholar
• Morris DL, Fernando MMA, Taylor KE, et al. MHC associations with clinical and autoantibody manifestations in European SLE. Genes Immunity. 2014;15(4):210–217. doi: 10.1038/gene.2014.6
   PubMed Web of Science ®Google Scholar
• Langefeld CD, Ainsworth HC, Graham DSC, et al. Transancestral mapping and genetic load in systemic lupus erythematosus. Nat Commun. 2017;8(1). doi: 10.1038/ncomms16021
   PubMedGoogle Scholar
• Hanscombe KB, Morris DL, Noble JA, et al. Genetic fine mapping of systemic lupus erythematosus MHC associations in Europeans and African Americans. Hum Mol Genet. 2018;27(21):3813–3824. doi: 10.1093/hmg/ddy280
   PubMed Web of Science ®Google Scholar
• Yang Y, Chung EK, Wu YL, et al. Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. Am J Hum Genet. 2007;80(6):1037–1054. doi: 10.1086/518257
   PubMed Web of Science ®Google Scholar
• Kamitaki N, Sekar A, Handsaker RE, et al. Complement genes contribute sex-biased vulnerability in diverse disorders. Nature. 2020;582(7813):577–581. doi: 10.1038/s41586-020-2277-x
   PubMed Web of Science ®Google Scholar
• Costa M, Poppelaars F, Kooten C, et al. Age and sex-associated changes of complement activity and complement levels in a healthy caucasian population. Front Immunol. 2018;9. doi: 10.3389/fimmu.2018.02664
   Web of Science ®Google Scholar
• Deng Y, Tsao BP. Advances in lupus genetics and epigenetics. Curr Opin Rheumatol. 2014;26(5):482–492. doi: 10.1097/BOR.0000000000000086
   PubMed Web of Science ®Google Scholar
• Cui Y, Sheng Y, Zhang X. Genetic susceptibility to SLE: recent progress from GWAS. J Autoimmun. 2013;41:25–33. doi: 10.1016/j.jaut.2013.01.008
   PubMed Web of Science ®Google Scholar
• Ota M, Nagafuchi Y, Hatano H, et al. Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases. Cell. 2021;184(11):3006–21.e17. doi: 10.1016/j.cell.2021.03.056
   PubMed Web of Science ®Google Scholar
• Kundaje A, Meuleman W, Ernst J, et al. Integrative analysis of 111 reference human epigenomes. Nature. 2015;518(7539):317–330. doi: 10.1038/nature14248
   PubMed Web of Science ®Google Scholar
• Ghodke-Puranik Y, Jin Z, Zimmerman KD, et al. Single-cell expression quantitative trait loci (eQTL) analysis of SLE-risk loci in lupus patient monocytes. Arthritis Res Ther. 2021;23(1):290. doi: 10.1186/s13075-021-02660-2
   PubMed Web of Science ®Google Scholar
• Perez RK, Gordon MG, Subramaniam M, et al. Single-cell RNA-seq reveals cell type–specific molecular and genetic associations to lupus. Science. 2022;376(6589). doi: 10.1126/science.abf1970
   Web of Science ®Google Scholar
• Yin X, Kim K, Suetsugu H, et al. Biological insights into systemic lupus erythematosus through an immune cell-specific transcriptome-wide association study. Ann Rheumatic Dis. 2022;81(9):1273–1280. doi: 10.1136/annrheumdis-2022-222345
   PubMed Web of Science ®Google Scholar
• Yazar S, Alquicira-Hernandez J, Wing K, et al. Single-cell eQTL mapping identifies cell type–specific genetic control of autoimmune disease. Science. 2022;376(6589). doi: 10.1126/science.abf3041
   PubMed Web of Science ®Google Scholar
• Võsa U, Claringbould A, Westra H-J, et al. Large-scale cis- and trans-Eqtl analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nature Genet. 2021;53(9):1300–1310. doi: 10.1038/s41588-021-00913-z
   PubMed Web of Science ®Google Scholar
• Patwardhan RP, Lee C, Litvin O, et al. High-resolution analysis of DNA regulatory elements by synthetic saturation mutagenesis. Nature Biotechnol. 2009;27(12):1173–1175. doi: 10.1038/nbt.1589
   PubMed Web of Science ®Google Scholar
• Lu X, Chen X, Forney C, et al. Global discovery of lupus genetic risk variant allelic enhancer activity. Nat Commun. 2021;12(1). doi: 10.1038/s41467-021-21854-5
   Web of Science ®Google Scholar
• Bourges C, Groff AF, Burren OS, et al. Resolving mechanisms of immune-mediated disease in primary CD4 T cells. EMBO Mol Med. 2020;12(5). doi: 10.15252/emmm.202012112
   PubMed Web of Science ®Google Scholar
• Simeonov DR, Gowen BG, Boontanrart M, et al. Discovery of stimulation-responsive immune enhancers with CRISPR activation. Nature. 2017;549(7670):111–115. doi: 10.1038/nature23875
   PubMed Web of Science ®Google Scholar
• Fulco CP, Nasser J, Jones TR, et al. Activity-by-contact model of enhancer-promoter regulation from thousands of CRISPR perturbations. Nat Genet. 2019;51(12):1664–1669. doi: 10.1038/s41588-019-0538-0
   PubMed Web of Science ®Google Scholar
• Taliun SAG, Evans DM, Schwartz R. Ten Simple rules for conducting a Mendelian randomization study. PLoS Comput Biol. 2021;17(8):e1009238. doi: 10.1371/journal.pcbi.1009238
   PubMed Web of Science ®Google Scholar
• Hingorani A, Humphries S. Nature’s randomised trials. Lancet. 2005;366(9501):1906–1908. doi: 10.1016/S0140-6736(05)67767-7
   PubMed Web of Science ®Google Scholar
• Lai C-H, Hsieh C-Y, Barnado A, et al. Outcomes of acute cardiovascular events in rheumatoid arthritis and systemic lupus erythematosus: a population-based study. Rheumatology. 2019;59(6):1355–1363. doi: 10.1093/rheumatology/kez456
   Web of Science ®Google Scholar
• Kain J, Owen KA, Marion MC, et al. Mendelian randomization and pathway analysis demonstrate shared genetic associations between lupus and coronary artery disease. Cell Rep Med. 2022;3(11):100805. doi: 10.1016/j.xcrm.2022.100805
   PubMedGoogle Scholar
• Tallbacka K, Pettersson T, Pukkala E. Increased incidence of cancer in systemic lupus erythematosus: a finnish cohort study with more than 25 years of follow-up. Scand J Rheumatol. 2018;47(6):461–464. doi: 10.1080/03009742.2017.1384054
   PubMed Web of Science ®Google Scholar
• Bae EH, Lim SY, Han K-D, et al. Systemic lupus erythematosus is a risk factor for cancer: a nationwide population-based study in Korea. Lupus. 2019;28(3):317–323. doi: 10.1177/0961203319826672
   PubMed Web of Science ®Google Scholar
• Zhang M, Wang Y, Wang Y, et al. Association between systemic lupus erythematosus and cancer morbidity and mortality: findings from cohort studies. Front Oncol. 2022;12:12. doi: 10.3389/fonc.2022.860794
   Web of Science ®Google Scholar
• Gu D, Tang M, Wang Y, et al. The causal relationships between extrinsic exposures and risk of prostate cancer: a phenome-wide mendelian randomization study. Front Oncol. 2022;12:12. doi: 10.3389/fonc.2022.829248
   Web of Science ®Google Scholar
• Peng H, Li C, Wu X, et al. Association between systemic lupus erythematosus and lung cancer: results from a pool of cohort studies and Mendelian randomization analysis. J Thoracic Dis. 2020;12(10):5299–5312. doi: 10.21037/jtd-20-2462
   PubMed Web of Science ®Google Scholar
• Moustafa AT, Moazzami M, Engel L, et al. Prevalence and metric of depression and anxiety in systemic lupus erythematosus: A systematic review and meta-analysis. Semin Arthritis Rheum. 2020;50(1):84–94. doi: 10.1016/j.semarthrit.2019.06.017
   PubMed Web of Science ®Google Scholar
• Chen J, Xu T, Wu M. Depression in systemic lupus erythematosus: modifiable or inheritable? a two-sample mendelian randomization study. Front Genet. 2022;13: doi: 10.3389/fgene.2022.988022
   Web of Science ®Google Scholar
• Luan HH, Wang A, Hilliard BK, et al. GDF15 is an inflammation-induced central mediator of tissue tolerance. Cell. 2019;178(5):1231–44.e11. doi: 10.1016/j.cell.2019.07.033
   PubMed Web of Science ®Google Scholar
• Ye D, Liu B, He Z, et al. Assessing the associations of growth differentiation factor 15 with rheumatic diseases using genetic data. Clin Epidemiol. 2021;13:245–252. doi: 10.2147/CLEP.S305024
   PubMed Web of Science ®Google Scholar
• Mo X, Guo Y, Qian Q, et al. Mendelian randomization analysis revealed potential causal factors for systemic lupus erythematosus. Immunology. 2019;159(3):279–288. doi: 10.1111/imm.13144
   PubMed Web of Science ®Google Scholar
• Chen L, Wang Y-F, Liu L, et al. Genome-wide assessment of genetic risk for systemic lupus erythematosus and disease severity. Hum Mol Genet. 2020;29(10):1745–1756. doi: 10.1093/hmg/ddaa030
   PubMed Web of Science ®Google Scholar
• Knevel R, Cessie S, Terao CC, et al. Using genetics to prioritize diagnoses for rheumatology outpatients with inflammatory arthritis. Sci, trans med. 2020;12(545). doi: 10.1126/scitranslmed.aay1548
   PubMed Web of Science ®Google Scholar
• Reid S, Alexsson A, Frodlund M, et al. High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosus. Ann Rheumatic Dis. 2019;79(3):363–369. doi: 10.1136/annrheumdis-2019-216227
   PubMed Web of Science ®Google Scholar
• Privé F, Aschard H, Carmi S, et al. Portability of 245 polygenic scores when derived from the UK Biobank and applied to 9 ancestry groups from the same cohort. Am J Hum Genet. 2022;109(1):12–23. doi: 10.1016/j.ajhg.2021.11.008
   PubMed Web of Science ®Google Scholar
• Xiu-Xiu S, Su-Su L, Man Z, et al. Association of HSP90B1 genetic polymorphisms with efficacy of glucocorticoids and improvement of HRQoL in systemic lupus erythematosus patients from Anhui Province. Am J Clin Exp Immunol. 2018;7:27–39.
   PubMed Web of Science ®Google Scholar
• Li S, Sun X, Xu J, et al. Association study of TRAP1 gene polymorphisms with susceptibility and glucocorticoids efficacy of systemic lupus erythematosus. Gene. 2018;671:117–126. doi: 10.1016/j.gene.2018.05.109
   PubMed Web of Science ®Google Scholar
• Robledo G, Márquez A, Dávila-Fajardo CL, et al. Association of the FCGR3A-158F/V gene polymorphism with the response to rituximab treatment in Spanish systemic autoimmune disease patients. DNA Cell Biol. 2012;31(12):1671–1677. doi: 10.1089/dna.2012.1799
   PubMed Web of Science ®Google Scholar
• Robinson JI, Yusof MYM, Davies V, et al. Comprehensive genetic and functional analyses of Fc gamma receptors influence on response to rituximab therapy for autoimmunity. EBioMedicine. 2022;86:104343. doi: 10.1016/j.ebiom.2022.104343
   PubMed Web of Science ®Google Scholar
• Attia DHS, Eissa M, Samy LA, et al. Influence of glutathione S transferase A1 gene polymorphism (-69C > T, rs3957356) on intravenous cyclophosphamide efficacy and side effects: a case-control study in Egyptian patients with lupus nephritis. Clin Rheumatol. 2020;40(2):753–762. doi: 10.1007/s10067-020-05276-0
   PubMed Web of Science ®Google Scholar
• Kim K, Bang S-Y, Joo YB, et al. Response to intravenous cyclophosphamide treatment for lupus nephritis associated with polymorphisms in the FCGR2B-FCRLA locus. J Rheumatol. 2016;43(6):1045–1049. doi: 10.3899/jrheum.150665
   PubMed Web of Science ®Google Scholar
• Ochoa D, Karim M, Ghoussaini M, et al. Human genetics evidence supports two-thirds of the 2021 FDA-approved drugs. Nat Rev Drug Discov. 2022;21(8):551–. doi: 10.1038/d41573-022-00120-3
   PubMed Web of Science ®Google Scholar
• Ghoussaini M, Mountjoy E, Carmona M, et al. Open targets genetics: systematic identification of trait-associated genes using large-scale genetics and functional genomics. Nucleic Acids Res. 2020;49(D1):D1311–D20. doi: 10.1093/nar/gkaa840
   Web of Science ®Google Scholar
• Zhang T, Klein A, Sang J, et al. ezQTL: a web platform for interactive visualization and colocalization of QTLs and GWAS Loci. Int J Genomics Proteomics. 2022;20(3):541–548. doi: 10.1016/j.gpb.2022.05.004
   Google Scholar
• Panjwani N, Wang F, Mastromatteo S, et al. LocusFocus: Web-based colocalization for the annotation and functional follow-up of GWAS. PLoS Comput Biol. 2020;16(10):e1008336. doi: 10.1371/journal.pcbi.1008336
   PubMed Web of Science ®Google Scholar
• Martin AR, Kanai M, Kamatani Y, et al. Clinical use of current polygenic risk scores may exacerbate health disparities. Nature Genet. 2019;51(4):584–591. doi: 10.1038/s41588-019-0379-x
   PubMed Web of Science ®Google Scholar
• Ochoa D, Hercules A, Carmona M, et al. Open Targets Platform: supporting systematic drug–target identification and prioritisation. Nucleic Acids Res. 2020;49(D1):D1302–D10. doi: 10.1093/nar/gkaa1027
   Web of Science ®Google Scholar
• Mueller M, Barros P, Witherden Abigail S, et al. Genomic pathology of sle-associated copy-number variation at the FCGR2C/FCGR3B/FCGR2B locus. Am J Hum Genet. 2013;92(1):28–40. doi: 10.1016/j.ajhg.2012.11.013
   PubMed Web of Science ®Google Scholar